BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 75 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $363,055 | -4.1% | 126,500 | +68.7% | 0.01% | 0.0% |
| Q2 2023 | $378,750 | +167.2% | 75,000 | 0.0% | 0.01% | +125.0% |
| Q1 2023 | $141,750 | -37.0% | 75,000 | -40.0% | 0.00% | -33.3% |
| Q4 2022 | $225,000 | +6.6% | 125,000 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $211,000 | +31.9% | 125,000 | +91.7% | 0.01% | +50.0% |
| Q2 2022 | $160,000 | -25.2% | 65,200 | -15.5% | 0.00% | 0.0% |
| Q1 2022 | $214,000 | – | 77,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 634,191 | $1,820,128 | 2.14% |
| NEA Management Company, LLC | 4,448,757 | $12,767,933 | 0.99% |
| CHI Advisors LLC | 720,000 | $2,066,400 | 0.82% |
| Bellevue Group AG | 8,135,839 | $23,349,858 | 0.38% |
| Parkman Healthcare Partners LLC | 520,587 | $1,494,085 | 0.27% |
| Artal Group S.A. | 2,046,517 | $5,874 | 0.25% |
| RA Capital Management | 3,525,754 | $10,118,914 | 0.20% |
| Ikarian Capital, LLC | 555,572 | $1,594,492 | 0.19% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,148,000 | 0.16% |
| Newtyn Management, LLC | 205,000 | $588,350 | 0.14% |